This invention relates to the use of a biomaterial for the treatment, repair and/or enhancement of bodily tissue insufficiencies of the vocal chords, muscles, ligaments, cartilage, post-operative regions, sexual organs and/or weight supporting areas of the feet as well as other conditions of the bones and joints. The biomaterial for use in the invention may comprise an injectable bioresorbable polysaccharide composition wherein the polysaccharide may be succinochitosan glutamate. This invention also relates to the use of a biomaterial comprising an injectable bioresorbable polysaccharide composition in which resorbable particles may be in suspension, the said particles comprising or consisting essentially of chitin and/or chitosan, which may be free of any additional formulation modifying agents, and a process for manufacturing the same. The invention also includes the use of various medicaments in the biomaterial formulations to enhance the treatment of the affected area of the body.
Methods Of Use Of Biomaterial And Injectable Implant Containing Biomaterial
This invention relates to the use of a biomaterial for the treatment, repair and/or enhancement of bodily tissue insufficiencies of the vocal chords, muscles, ligaments, cartilage, post-operative regions, sexual organs and/or weight supporting areas of the feet as well as other conditions of the bones and joints. The biomaterial for use in the invention may comprise an injectable bioresorbable polysaccharide composition wherein the polysaccharide may be succinochitosan glutamate. This invention also relates to the use of a biomaterial comprising an injectable bioresorbable polysaccharide composition in which resorbable particles may be in suspension, the said particles comprising or consisting essentially of chitin and/or chitosan, which may be free of any additional formulation modifying agents, and a process for manufacturing the same. The invention also includes the use of various medicaments in the biomaterial formulations to enhance the treatment of the affected area of the body.
Methods Of Use Of Biomaterial And Injectable Implant Containing Biomaterial
This invention relates to the use of a biomaterial for the treatment, repair and/or enhancement of bodily tissue insufficiencies of the vocal chords, muscles, ligaments, cartilage, post-operative regions, sexual organs and/or weight supporting areas of the feet as well as other conditions of the bones and joints. The biomaterial for use in the invention may comprise an injectable bioresorbable polysaccharide composition wherein the polysaccharide may be succinochitosan glutamate. This invention also relates to the use of a biomaterial comprising an injectable bioresorbable polysaccharide composition in which resorbable particles may be in suspension, the said particles comprising or consisting essentially of chitin and/or chitosan, which may be free of any additional formulation modifying agents, and a process for manufacturing the same. The invention also includes the use of various medicaments in the biomaterial formulations to enhance the treatment of the affected area of the body.
Methods Of Use Of Biomaterial And Injectable Implant Containing Biomaterial
This invention relates to the use of a biomaterial for the treatment, repair and/or enhancement of bodily tissue insufficiencies of the vocal chords, muscles, ligaments, cartilage, post-operative regions, sexual organs and/or weight supporting areas of the feet as well as other conditions of the bones and joints. The biomaterial for use in the invention may comprise an injectable bioresorbable polysaccharide composition wherein the polysaccharide may be succinochitosan glutamate. This invention also relates to the use of a biomaterial comprising an injectable bioresorbable polysaccharide composition in which resorbable particles may be in suspension, the said particles comprising or consisting essentially of chitin and/or chitosan, which may be free of any additional formulation modifying agents, and a process for manufacturing the same. The invention also includes the use of various medicaments in the biomaterial formulations to enhance the treatment of the affected area of the body.
Name / Title
Company / Classification
Phones & Addresses
Robert J. Bitterman Chief Executive Officer, President
Cutanea Life Sciences, Inc. Pharmaceuticals · Noncommercial Research Organization
1500 Liberty Rdg Dr SUITE 3000, Wayne, PA 19087 5 Great Vly Pkwy, Frazer, PA 19355 PO Box 271, Wayne, PA 19087 (484)5680100, (484)3283214
Robert J. Bitterman Director
RXi Pharmaceuticals Corporation Biotechnology · A Development Stage Company Engaged In Biopharmaceutical Preparations · Biopharmaceutical Preparations · Mfg Pharmaceutical Preparations
257 Simarano Dr SUITE 101, Marlborough, MA 01752 1500 W Park Dr, Westboro, MA 01581 60 Prescott St, Worcester, MA 01605 (508)7673861
May 2011 to Present AssociateVanguard Wayne, PA Sep 2010 to Apr 2011 Retail Processing AssociateRecordtrak Inc King of Prussia, PA Sep 2009 to Sep 2010 Accounts RepresentativeCutanea Life Sciences, Inc Malvern, PA Jan 2009 to Aug 2009 AssociateSquashSmarts, Inc. Philadelphia, PA Oct 2007 to Oct 2008 Service & Leadership DirectorCutanea Life Sciences, Inc. Malvern, PA Dec 2006 to Jul 2007 Assistant to Regulatory Affairs Director
Education:
Washington & Lee University Lexington, VA 2001 to 2005 B.A. Economics
Skills:
Database Management, Large Transactions, Market Research